Lumera Lines up $25M in Equity Financing over Three Years | GenomeWeb

NEW YORK (GenomeWeb News) - Lumera said today it will have access to as much as $25 million in financing over the next three years through an equity financing agreement with investment bank Kingsbridge Capital Limited.

Lumera, which will choose the timing and amount of any of the committed equity financing facility purchases, plans to use the funds to support corporate and research and development activities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.